Intact Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Buy
64,629
+9,900
+18% +$2.31M 0.47% 53
2026
Q1
$13.4M Hold
54,729
0.38% 66
2025
Q4
$11.3M Sell
54,729
-2,400
-4% -$475K 0.33% 72
2025
Q3
$10.6M Sell
57,129
-14,260
-20% -$2.44M 0.32% 73
2025
Q2
$10.9M Sell
71,389
-15,900
-18% -$2.44M 0.37% 70
2025
Q1
$14.5M Buy
87,289
+2,700
+3% +$422K 0.5% 56
2024
Q4
$12.2M Sell
84,589
-7,220
-8% -$1.12M 0.43% 62
2024
Q3
$14.9M Buy
91,809
+17,320
+23% +$2.76M 0.49% 50
2024
Q2
$10.9M Buy
74,489
+11,500
+18% +$1.71M 0.41% 56
2024
Q1
$9.96M Sell
62,989
-4,200
-6% -$669K 0.39% 62
2023
Q4
$10.5M Sell
67,189
-19,700
-23% -$3.02M 0.43% 55
2023
Q3
$13.5M Sell
86,889
-4,611
-5% -$761K 0.59% 41
2023
Q2
$15.1M Buy
91,500
+4,500
+5% +$726K 0.62% 39
2023
Q1
$13.5M Buy
87,000
+21,000
+32% +$3.39M 0.56% 41
2022
Q4
$11.7M Sell
66,000
-800
-1% -$138K 0.51% 50
2022
Q3
$10.9M Buy
66,800
+4,300
+7% +$728K 0.36% 59
2022
Q2
$11.1M Sell
62,500
-1,700
-3% -$303K 0.35% 66
2022
Q1
$11.4M Sell
64,200
-14,300
-18% -$2.43M 0.29% 75
2021
Q4
$13.4M Hold
78,500
0.34% 66
2021
Q3
$12.7M Hold
78,500
0.35% 60
2021
Q2
$12.9M Hold
78,500
0.37% 59
2021
Q1
$12.9M Sell
78,500
-1,700
-2% -$275K 0.39% 56
2020
Q4
$12.6M Buy
80,200
+3,300
+4% +$487K 0.41% 55
2020
Q3
$11.4M Buy
76,900
+4,700
+7% +$695K 0.4% 53
2020
Q2
$10.1M Sell
72,200
-6,700
-8% -$976K 0.38% 55
2020
Q1
$10.3M Sell
78,900
-6,000
-7% -$851K 0.45% 49
2019
Q4
$12.4M Buy
84,900
+20,200
+31% +$2.74M 0.42% 56
2019
Q3
$8.37M Sell
64,700
-800
-1% -$105K 0.3% 69
2019
Q2
$9.11M Sell
65,500
-17,400
-21% -$2.41M 0.33% 64
2019
Q1
$11.6M Sell
82,900
-39,600
-32% -$5.3M 0.41% 50
2018
Q4
$15.8M Hold
122,500
0.64% 32
2018
Q3
$16.9M Buy
122,500
+11,900
+11% +$1.58M 0.6% 35
2018
Q2
$13.4M Buy
110,600
+59,300
+116% +$7.4M 0.48% 42
2018
Q1
$6.57M Sell
51,300
-17,700
-26% -$2.39M 0.25% 73
2017
Q4
$9.65M Buy
69,000
+1,600
+2% +$223K 0.39% 61
2017
Q3
$8.76M Buy
67,400
+600
+0.9% +$79.5K 0.38% 58
2017
Q2
$8.84M Sell
66,800
-41,600
-38% -$5.31M 0.39% 55
2017
Q1
$13.5M Sell
108,400
-48,400
-31% -$5.78M 0.55% 50
2016
Q4
$18.1M Buy
156,800
+11,100
+8% +$1.28M 0.67% 46
2016
Q3
$17.2M Sell
145,700
-4,500
-3% -$546K 0.65% 48
2016
Q2
$18.2M Sell
150,200
-1,700
-1% -$193K 0.74% 41
2016
Q1
$16.4M Sell
151,900
-59,500
-28% -$6.16M 0.67% 40
2015
Q4
$21.7M Sell
211,400
-20,500
-9% -$2.06M 0.97% 28
2015
Q3
$21.6M Sell
231,900
-300
-0.1% -$29K 0.97% 30
2015
Q2
$22.6M Buy
232,200
+13,900
+6% +$1.39M 0.93% 31
2015
Q1
$22M Buy
218,300
+38,900
+22% +$3.96M 0.89% 34
2014
Q4
$18.8M Buy
179,400
+76,200
+74% +$8.03M 0.75% 38
2014
Q3
$11M Buy
103,200
+45,900
+80% +$4.76M 0.45% 45
2014
Q2
$5.99M Sell
57,300
-4,460
-7% -$451K 0.24% 55
2014
Q1
$6.07M Buy
61,760
+47,960
+348% +$4.45M 0.27% 55
2013
Q4
$1.26M Hold
13,800
0.06% 87
2013
Q3
$1.2M Buy
13,800
+8,900
+182% +$798K 0.06% 79
2013
Q2
$421K Buy
+4,900
New +$416K 0.02% 89

Other funds holding JNJ

Intact Investment Management's JNJ Position: Q2 2026 in Review

Intact Investment Management increased its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, buying an estimated $2.31M and bringing the position to 64,629 shares worth $16.4M. The position accounts for 0.47% of the portfolio, ranked #53.

Intact Investment Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.6M in Q2 2015. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Intact Investment Management held 64,629 shares of Johnson & Johnson worth $16.4M as of Q2 2026.
  • Intact Investment Management bought 9,900 Johnson & Johnson shares in Q2 2026, an estimated $2.31M.
  • Johnson & Johnson made up 0.47% of Intact Investment Management's portfolio in Q2 2026, its #53 holding.
  • Intact Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Intact Investment Management's Johnson & Johnson position peaked at $22.6M in Q2 2015.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.